RESUMO
OBJECTIVE: To estimate the reference range of tissue oxygen saturation (StO2) values in pregnancy. Near-infrared spectroscopy-derived StO2 is a noninvasive continuous measure used to predict hypoperfusion. Normal StO2 values have not been established in pregnant women. STUDY DESIGN: We enrolled 154 healthy pregnant women from an obstetric and gynecology resident clinic. Three sequential measurements were taken after securing the StO2 probe to the thenar eminence of one hand. One-way ANOVA was used to test for differences between trimesters and non-parametric methods to establish a reference range with 95% CI on the limits. RESULTS: The reference interval for the entire cohort of pregnant women is 73% (95% CI 72-75) to 92% (95% CI 89-93), similar to the normal range in the general population. We found no statistically significant difference in StO2 measurements between trimesters. Due to inadequate sample sizes we could not estimate a valid reference range for each trimester. CONCLUSION: We estimated a reference range for StO2 values in normal pregnant women. This information may contribute to the study of StO2 monitoring to predict impending shock in the obstetric patient.
Assuntos
Oxigênio/metabolismo , Gravidez/metabolismo , Espectroscopia de Luz Próxima ao Infravermelho , Adolescente , Adulto , Feminino , Humanos , Oximetria , Valores de Referência , Adulto JovemRESUMO
This paper presents the composite drought indicator (CDI) that Jordanian, Lebanese, Moroccan, and Tunisian government agencies now produce monthly to support operational drought management decision making, and it describes their iterative co-development processes. The CDI is primarily intended to monitor agricultural and ecological drought on a seasonal time scale. It uses remote sensing and modelled data inputs, and it reflects anomalies in precipitation, vegetation, soil moisture, and evapotranspiration. Following quantitative and qualitative validation assessments, engagements with policymakers, and consideration of agencies' technical and institutional capabilities and constraints, we made changes to CDI input data, modelling procedures, and integration to tailor the system for each national context. We summarize validation results, drought modelling challenges and how we overcame them through CDI improvements, and we describe the monthly CDI production process and outputs. Finally, we synthesize procedural and technical aspects of CDI development and reflect on the constraints we faced as well as trade-offs made to optimize the CDI for operational monitoring to support policy decision-making-including aspects of salience, credibility, and legitimacy-within each national context.
RESUMO
Cesarean scar pregnancy (CSP) is a very serious complication of a prior cesarean delivery. The major risks associated with CSP are uncontrolled hemorrhage and uterine rupture, potentially leading to future infertility. Management of CSP remains a major obstetric challenge without a well-defined therapeutic procedure. Dilation & curettage is a commonly used procedure for the treatment of CSP. However, it can be ineffective and often leads to definite infertility. Therefore, we present a case of the successful use of an alternative procedure, Myosure® hysteroscopy, in the treatment of CSP. We herein report the case of a 32-year-old G5P3013 woman who presented with vaginal bleeding and past history of three cesarean sections. She was found to have a CSP with fetal pole and cardiac activity at 6 weeks 2 days. The patient was initially treated with a systemic methotrexate injection, but there was persistence of cardiac activity. A second course of methotrexate was administered into the gestational sac, which systemically led to successful fetal cardiac arrest and downtrend of beta-human chorionic gonadotropin (HCG) level. A dilation & curettage procedure was not successful in removing products of conception. A Myosure hysteroscopy procedure, however, was successful in removing products of conception. The patient was discharged after a negative ultrasound and beta-HCG level. In our review of the literature, we found that there is no general consensus on the management of cesarean scar ectopic pregnancies. To date, there is no literature cited about the use of Myosure for cesarean scar ectopic pregnancies. However, our case suggests that Myosure can be effective for CSP and this warrants a larger-scale controlled study to better evaluate this as a treatment for this condition.
RESUMO
Previable preterm premature rupture of membranes (PV-PPROM) is defined as rupture of membranes prior to 24 weeks and is a rare phenomenon with an estimated prevalence of 0.5% of all pregnancies. Given that this phenomenon is even more rare in patients with dichorionic diamniotic (DCDA) twin pregnancies, there is no clear consensus in the literature on outcomes and management of DCDA PV-PPROM due to the scarcity of reports. We report a case of a rare successful prolongation of first trimester DCDA PV-PPROM pregnancy with rupture of the amniotic sac of one twin with survival of both twins without major complications. A 20-year-old female gravida 1 para 0 at about 13 weeks and three days presented with vaginal watery discharge mixed with vaginal bleeding. Abdominal ultrasound revealed a live twin dichorionic diamniotic (DCDA) spontaneous intrauterine gestation and a significantly low amniotic fluid volume involving fetus A. At 23 weeks gestational age, she experienced increased leaking of clear fluid, and she was admitted to the hospital for continuous monitoring with daily non-stress tests (NST), and ultrasounds every four weeks, and received antibiotics, betamethasone, and magnesium. Preterm labor occurred at 30w1d, and a primary low transverse cesarean section was performed on the 114th day after PPROM. Though, twin A required prolonged hospitalization both twins recovered and progressed well without complications. To the best of our knowledge, this is the longest case of successful expectant management of both twins with PV-PPROM yet reported.
RESUMO
OBJECTIVE: To describe the success rate of and the quality of life after global endometrial ablation in an obese population. METHODS: A follow-up survey was mailed to 72 women who had undergone global endometrial ablation. The survey included a menorrhagia-specific NovaSure endometrial ablation questionnaire. The mean follow-up time was 2.5years. RESULTS: Forty-four women (61%) responded, with a mean body mass index (BMI, calculated as weight in kilograms divided by the square of height in meters) of 30.5. Overall, patients reported a decrease in missed social activities, in inability to perform activities of daily living, in missed work days, in bleeding tendencies, and in pain. The amenorrhea rate was 37%, and the success rate (those not requiring any further therapeutic treatment) was 86%. Patient satisfaction was 93%. CONCLUSION: Global endometrial ablation improved quality of life for obese women with menorrhagia and had a high rate of satisfaction, even for patients not achieving amenorrhea. Patients with a BMI of more than 34 showed a trend toward failure and a higher rate of hysterectomy.